Your browser doesn't support javascript.
loading
Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials.
Raabe, Vanessa N; Lighter, Jennifer; Caplan, Arthur L; Ratner, Adam J.
Afiliação
  • Raabe VN; Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA.
  • Lighter J; Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine and NYU Langone Vaccine Center, New York, New York, USA.
  • Caplan AL; Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA.
  • Ratner AJ; Department of Population Health, Division of Bioethics, New York University Grossman School of Medicine, New York, New York, USA.
Clin Infect Dis ; 71(12): 3248-3249, 2020 12 15.
Article em En | MEDLINE | ID: mdl-32459832
ABSTRACT
Pediatric patients are excluded from most coronavirus disease 2019 (COVID-19) therapeutic trials. We outline a rationale for the inclusion of children in COVID-19 therapeutic trials, which enabled us to include children of all ages in a therapeutic COVID-19 trial at our institution.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Infecções por Coronavirus / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Adolescent / Child / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Infecções por Coronavirus / COVID-19 / Tratamento Farmacológico da COVID-19 Limite: Adolescent / Child / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article